South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on aα4β7 for replication

Retrovirology

Volumn 12, Issue 1, 2015, Pages

  Richardson, Simone I ^a,b   Gray, Elin S ^a,g   Mkhize, Nonhlanhla N ^a,b   Sheward, Daniel J ^c   Lambson, Bronwen E ^a,b   Wibmer, Constantinos Kurt ^a,b   Masson, Lindi ^c   Werner, Lise ^d   Garrett, Nigel ^d   Passmore, Jo Ann S ^c,d,e   Karim, Quarraisha Abdool ^d   Karim, Salim S Abdool ^d,f   Williamson, Carolyn ^c,d,e   Moore, Penny L ^a,b,d   Morris, Lynn ^a,b,d  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f Och Spine at New York Presbyterian Hospitals   (United States)

^g EDITH COWAN UNIVERSITY   (Australia)

Author keywords

a 4 7; Bacterial vaginosis; Cytokines; HIV entry; Tripeptide binding motif

Indexed keywords

ALPHA4BETA7 INTEGRIN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160; INTEGRIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 7; INTERLEUKIN 8; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY ACT 1; MONOCLONAL ANTIBODY HP2 1; PROLINE; RETINOIC ACID; SERYLASPARTYLISOLEUCINE; TRIPEPTIDE; UNCLASSIFIED DRUG; VALINE; GP120 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; INTEGRIN ALPHA4BETA7;

AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DRUG PROTEIN BINDING; DRUG TARGETING; FEMALE; GENETIC VARIABILITY; GEOGRAPHIC ORIGIN; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE C; HUMAN TISSUE; NONHUMAN; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SPECIES COMPARISON; VAGINAL LAVAGE; VAGINITIS; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS IDENTIFICATION; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS MUTATION; VIRUS REPLICATION; VIRUS TRANSMISSION; CLASSIFICATION; GENETICS; GENOTYPE; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY; PROSPECTIVE STUDY; SOUTH AFRICA; VIROLOGY;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS 1;

FEMALE; GENOTYPE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; INTEGRINS; PROSPECTIVE STUDIES; SOUTH AFRICA; VIRUS REPLICATION;

EID: 84931441912     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/s12977-015-0183-3     Document Type: Article

References (61)

1. Lackner AA, Mohan M, Veazey RS (2009) The gastrointestinal tract and AIDS pathogenesis. Gastroenterology 136(6):1965-1978
2. Brenchley JM, Price DA, Douek DC (2006) HIV disease: fallout from a mucosal catastrophe? Nat Immunol 7(3):235-239. doi: 10.1038/ni1316
3. Arthos J, Cicala C, Martinelli E, Macleod K, Van Ryk D, Wei D et al (2008) HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat Immunol 9(3):301-309. doi: 10.1038/ni1566
4. Mestecky J, Fultz PN (1999) Mucosal immune system of the human genital tract. J Infect Dis 179(Suppl 3):S470-S474. doi: 10.1086/314806
5. Berlin C, Berg EL, Briskin MJ, Andrew DP, Kilshaw PJ, Holzmann B et al (1993) Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74(1):185-195
6. von Andrian UH, Mackay CR (2000) T-cell function and migration. Two sides of the same coin. N Engl J Med 343(14):1020-1034. doi: 10.1056/NEJM200010053431407
7. Kelly KA, Chan AM, Butch A, Darville T (2009) Two different homing pathways involving integrin beta7 and E-selectin significantly influence trafficking of CD4 cells to the genital tract following Chlamydia muridarum infection. Am J Reprod Immunol 61(6):438-445. doi: 10.1111/j.1600-0897.2009.00704.x
8. McKinnon LR, Nyanga B, Chege D, Izulla P, Kimani M, Huibner S et al (2011) Characterization of a human cervical CD4+ T cell subset coexpressing multiple markers of HIV susceptibility. J Immunol 187(11):6032-6042. doi: 10.4049/jimmunol.1101836
9. Cicala C, Martinelli E, McNally JP, Goode DJ, Gopaul R, Hiatt J et al (2009) The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc Natl Acad Sci USA 106(49):20877-20882. doi: 10.1073/pnas.0911796106
10. Andrew DP, Berlin C, Honda S, Yoshino T, Hamann A, Holzmann B et al (1994) Distinct but overlapping epitopes are involved in alpha 4 beta 7-mediated adhesion to vascular cell adhesion molecule-1, mucosal addressin-1, fibronectin, and lymphocyte aggregation. J Immunol 153(9):3847-3861
11. Jackson DY (2002) Alpha 4 integrin antagonists. Curr Pharm Des 8(14):1229-1253
12. Zeller Y, Mechtersheimer S, Altevogt P (2001) Critical amino acid residues of the alpha4 subunit for alpha4beta7 integrin function. J Cell Biochem 83(2):304-319
13. Schiffer SG, Day E, Latanision SM, Tizard R, Osborn L (1995) An alternately spliced mRNA encoding functional domains of murine MAdCAM-1. Biochem Biophys Res Commun 216(1):170-176. doi: 10.1006/bbrc.1995.2606
14. Kwong PD, Doyle ML, Casper DJ, Cicala C, Leavitt SA, Majeed S et al (2002) HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 420(6916):678-682. doi: 10.1038/nature01188
15. Hait SH, Darc M, Machado ES, Soares EA, Sprinz E, Soares MA (2014) Conservation of the alpha4beta7 lymphocyte homing receptor in HIV-infected patients with distinct transmission routes and disease progression profiles. AIDS Res Hum Retroviruses 30(5):493-497. doi: 10.1089/AID.2013.0248
16. He X, Mokili JL, Hong K, Chen J, Wei J, Xin R et al (2011) Conservancy of the alpha4beta7 integrin mimotope in the V2 domain of HIV type 1 CRF07_BC compared to subtype B' strains in China. AIDS Res Hum Retroviruses 27(10):1127-1133. doi: 10.1089/AID.2011.0007
17. Tassaneetrithep B, Tivon D, Swetnam J, Karasavvas N, Michael NL, Kim JH et al (2014) Cryptic determinant of alpha4beta7 binding in the V2 loop of HIV-1 gp120. PLoS One 9(9):e108446. doi: 10.1371/journal.pone.0108446
18. Zhou T, Xu L, Dey B, Hessell AJ, Van Ryk D, Xiang SH et al (2007) Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 445(7129):732-737. doi: 10.1038/nature05580
19. Parrish NF, Wilen CB, Banks LB, Iyer SS, Pfaff JM, Salazar-Gonzalez JF et al (2012) Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin alpha4beta7. PLoS Pathog 8(5):e1002686. doi: 10.1371/journal.ppat.1002686
20. Perez LG, Chen H, Liao HX, Montefiori DC (2014) Envelope glycoprotein binding to the integrin alpha4beta7 is not a general property of most HIV-1 strains. J Virol 88(18):10767-10777. doi: 10.1128/JVI.03296-13
21. Etemad B, Gonzalez OA, McDonough S, Pena-Cruz V, Sagar M (2013) Early infection HIV-1 envelope V1-V2 genotypes do not enhance binding or replication in cells expressing high levels of alpha4beta7 integrin. J Acquir Immune Defic Syndr 64(3):249-253. doi: 10.1097/QAI.0b013e3182a06ddd
22. Byrareddy SN, Kallam B, Arthos J, Cicala C, Nawaz F (2014) Targeting aα4β7 integrin reduces mucosal transmission of SIV and protects GALT from infection. Nat Med (in press)
23. Ansari AA, Reimann KA, Mayne AE, Takahashi Y, Stephenson ST, Wang R et al (2011) Blocking of alpha4beta7 gut-homing integrin during acute infection leads to decreased plasma and gastrointestinal tissue viral loads in simian immunodeficiency virus-infected rhesus macaques. J Immunol 186(2):1044-1059. doi: 10.4049/jimmunol.1003052
24. Martinelli E, Veglia F, Goode D, Guerra-Perez N, Aravantinou M, Arthos J et al (2013) The frequency of alpha4beta7high memory CD4+ T cells correlates with susceptibility to rectal SIV infection. J Acquir Immune Defic Syndr. doi: 10.1097/QAI.0b013e31829f6e1a
25. Goode D, Truong R, Villegas G, Calenda G, Guerra-Perez N, Piatak M et al (2014) HSV-2-driven increase in the expression of alpha4beta7 correlates with increased susceptibility to vaginal SHIV(SF162P3) infection. PLoS Pathog 10(12):e1004567. doi: 10.1371/journal.ppat.1004567
26. van Loggerenberg F, Mlisana K, Williamson C, Auld SC, Morris L, Gray CM et al (2008) Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study. PLoS One 3(4):e1954. doi: 10.1371/journal.pone.0001954
27. Nawaz F, Cicala C, Van Ryk D, Block KE, Jelicic K, McNally JP et al (2011) The genotype of early-transmitting HIV gp120 s promotes alpha (4) beta(7)-reactivity, revealing alpha (4) beta(7) +/CD4+ T cells as key targets in mucosal transmission. PLoS Pathog 7(2):e1001301. doi: 10.1371/journal.ppat.1001301
28. Hildreth JE, Orentas RJ (1989) Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science 244(4908):1075-1078
29. Pena-Cruz V, Etemad B, Chatziandreou N, Nyein PH, Stock S, Reynolds SJ et al (2013) HIV-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners. Retrovirology 10:162. doi: 10.1186/1742-4690-10-162
30. Martinelli E, Tharinger H, Frank I, Arthos J, Piatak M Jr, Lifson JD et al (2011) HSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target. PLoS Pathog 7(6):e1002109. doi: 10.1371/journal.ppat.1002109
31. Nagai K, Larkin S, Hartnell A, Larbi K, Razi Aghakhani M, Windley C et al (1999) Human eotaxin induces eosinophil extravasation through rat mesenteric venules: role of alpha4 integrins and vascular cell adhesion molecule-1. Immunology 96(2):176-183
32. Brenchley JM, Douek DC (2008) HIV infection and the gastrointestinal immune system. Mucosal Immunol 1(1):23-30. doi: 10.1038/mi.2007.1
33. Li Y, O'Dell S, Walker LM, Wu X, Guenaga J, Feng Y et al (2011) Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01. J Virol 85(17):8954-8967. doi: 10.1128/JVI.00754-11
34. Bar S, Alizon M (2004) Role of the ectodomain of the gp41 transmembrane envelope protein of human immunodeficiency virus type 1 in late steps of the membrane fusion process. J Virol 78(2):811-820
35. Moore PL, Gray ES, Wibmer CK, Bhiman JN, Nonyane M, Sheward DJ et al (2012) Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape. Nat Med 18(11):1688-1692. doi: 10.1038/nm.2985
36. Pancera M, Zhou T, Druz A, Georgiev IS, Soto C, Gorman J et al (2014) Structure and immune recognition of trimeric pre-fusion HIV-1 Env. Nature. doi: 10.1038/nature13808
37. Moore PL, Crooks ET, Porter L, Zhu P, Cayanan CS, Grise H et al (2006) Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. J Virol 80(5):2515-2528. doi: 10.1128/JVI.80.5.2515-2528.2006
38. Levine WC, Pope V, Bhoomkar A, Tambe P, Lewis JS, Zaidi AA et al (1998) Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis 177(1):167-174
39. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N et al (1993) Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. Aids 7(1):95-102
40. Mlisana K, Naicker N, Werner L, Roberts L, van Loggerenberg F, Baxter C et al (2012) Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis 206(1):6-14. doi: 10.1093/infdis/jis298
41. Stamm WE, Handsfield HH, Rompalo AM, Ashley RL, Roberts PL, Corey L (1988) The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA J Am Med Assoc 260(10):1429-1433
42. Kelly KA, Natarajan S, Ruther P, Wisse A, Chang MH, Ault KA (2001) Chlamydia trachomatis infection induces mucosal addressin cell adhesion molecule-1 and vascular cell adhesion molecule-1, providing an immunologic link between the fallopian tube and other mucosal tissues. J Infect Dis 184(7):885-891. doi: 10.1086/323341
43. Fredricks DN, Fiedler TL, Marrazzo JM (2005) Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 353(18):1899-1911. doi: 10.1056/NEJMoa043802
44. Cohen CR, Lingappa JR, Baeten JM, Ngayo MO, Spiegel CA, Hong T et al (2012) Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med 9(6):e1001251. doi: 10.1371/journal.pmed.1001251
45. Nwadioha S, Egah D, Banwat E, Egesie J, Onwuezobe I (2011) Prevalence of bacterial vaginosis and its risk factors in HIV/AIDS patients with abnormal vaginal discharge. Asian Pacific J Tropic Med 4(2):156-158. doi: 10.1016/S1995-7645(11)60059-X
46. Masson L, Mlisana K, Little F, Werner L, Mkhize NN, Ronacher K et al (2014) Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study. Sex Transm Infect. doi: 10.1136/sextrans-2014-051601
47. Cimbro R, Vassena L, Arthos J, Cicala C, Kehrl JH, Park C et al (2012) IL-7 induces expression and activation of integrin alpha4beta7 promoting naive T-cell homing to the intestinal mucosa. Blood 120(13):2610-2619. doi: 10.1182/blood-2012-06-434779
48. Cauci S, Driussi S, De Santo D, Penacchioni P, Iannicelli T, Lanzafame P et al (2002) Prevalence of bacterial vaginosis and vaginal flora changes in peri- and postmenopausal women. J Clin Microbiol 40(6):2147-2152
49. Hedges SR, Barrientes F, Desmond RA, Schwebke JR (2006) Local and systemic cytokine levels in relation to changes in vaginal flora. J Infect Dis 193(4):556-562. doi: 10.1086/499824
50. Losikoff P, Fichorova R, Snyder B, Rodriguez I, Cu-Uvin S, Harwell J et al (2007) Genital tract interleukin-8 but not interleukin-1beta or interleukin-6 concentration is associated with bacterial vaginosis and its clearance in HIV-infected and HIV-uninfected women. Infect Dis Obstet Gynecol 2007:92307. doi: 10.1155/2007/92307
51. Ryckman KK, Williams SM, Kalinka J (2008) Correlations of selected vaginal cytokine levels with pregnancy-related traits in women with bacterial vaginosis and mycoplasmas. J Reprod Immunol 78(2):172-180. doi: 10.1016/j.jri.2008.02.001
52. Yu Y, Zhu J, Huang PS, Wang JH, Pullen N, Springer TA (2013) Domain 1 of mucosal addressin cell adhesion molecule has an I1-set fold and a flexible integrin-binding loop. J Biol Chem 288(9):6284-6294. doi: 10.1074/jbc.M112.413153
53. Dubree NJ, Artis DR, Castanedo G, Marsters J, Sutherlin D, Caris L et al (2002) Selective alpha4beta7 integrin antagonists and their potential as antiinflammatory agents. J Med Chem 45(16):3451-3457
54. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY (2004) Retinoic acid imprints gut-homing specificity on T cells. Immunity 21(4):527-538. doi: 10.1016/j.immuni.2004.08.011
55. WHO (2009) Global prevalence of vitamin A deficiency in populations at risk 1995-2005. WHO global database on vitamin A deficiency. World Health Organization, Geneva
56. Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, Kabat D (1998) Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol 72(4):2855-2864
57. Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM et al (2002) Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 46(6):1896-1905
58. Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H et al (2009) Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 206(6):1273-1289. doi: 10.1084/jem.20090378
59. Lu J, Sista P, Giguel F, Greenberg M, Kuritzkes DR (2004) Relative replicative fitness of human immunodeficiency virus type 1 mutants resistant to enfuvirtide (T-20). J Virol 78(9):4628-4637
60. Moore JP, McKeating JA, Weiss RA, Sattentau QJ (1990) Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250(4984):1139-1142
61. Zhang M, Gaschen B, Blay W, Foley B, Haigwood N, Kuiken C et al (2004) Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 14(12):1229-1246. doi: 10.1093/glycob/cwh106